Abstract

Get full access to this article
View all access options for this article.
References
1.
Lacy
C
Armstrong
LL
Ingrim
N
Lance
LL
. Drug information handbook . 4th ed.
Hudson, OH : APhA , 1996 .
2.
Miguet
JP
Mavier
P
Soussy
CJ
Dhumeauz
D
. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man . Gastroenterology
1977 ;72 : 924 –6 .
3.
Hebert
MF
Roberts
JP
Prueksaritanont
T
Benet
LZ
. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction . Clin Pharmacol Ther
1992 ;52 : 453 –7 .
4.
Van Buren
D
Wideman
CA
Ried
M
Gibbons
S
Van Buren
CT
Jarowenko
M
The antagonistic effect of rifampin upon cyclosporine bioavailability . Transplantation Proc
1984 ;16 :1642 –5 .
5.
Al Sulaiman
MH
Shar
JM
Al Khader
AA
. Successful use of rifampicin in the treatment of tuberculosis in renal transplant patients immunosuppressed with cyclosporine . Transplantation
1990 ;50 : 597 –8 .
6.
Rockwitz
J
Tunkel
AR
. Bacterial meningitis: Practical guidelines for management . Drugs
1995 ;50 : 838 –53 .
7.
Cuevas
LE
Hart
CA
. Chemoprophylaxis of bacterial meningitis . J Antimicrob Chemother
1993 ;31 (suppl B ): 79 –91 .
8.
Wandel
C
Bohrer
H
Bocker
R
. Rifampicin and cyclosporine dosing in heart transplant recipients . J Cardiothorac Vasc Anesth
1995 ;9 : 621 –2 .
